期刊
HEPATOLOGY RESEARCH
卷 42, 期 2, 页码 150-165出版社
WILEY
DOI: 10.1111/j.1872-034X.2011.00905.x
关键词
5-fluorouracil; FAIT; hepatic arterial infusion chemotherapy; hepatocellular carcinoma; interferon-a; portal vein
资金
- Otsuka Pharmaceutical
Aim: The efficacy and safety of 5-fluorouracil arterial infusion + interferon therapy (FAIT) was evaluated in patients with hepatocellular carcinoma (HCC) with a high degree of vascular invasion associated with poor prognosis, using best salvage therapy (BST) as a reference group.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
